Clinical Trial Update: Using End-Tidal CO₂ to Help Diagnose and Monitor Pulmonary Embolism

View source ↗

Summary

A completed clinical trial from Ataturk University evaluating end-tidal CO2 as a diagnostic and monitoring tool for acute pulmonary embolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Snippet

Sponsor: Ataturk University | Conditions: Pulmonary Embolism Acute | Status: COMPLETED